FDA moves to encourage A.I. in medicine, drug development - (CNBC via NewsPoints Desk)

  • The FDA is encouraging the use of artificial intelligence (AI) and other digital tools in medicine and drug development, and establishing a new incubator focused on health technology, called the Information Exchange and Data Transformation (INFORMED), CNBC reported Thursday.
  • "AI holds enormous promise for the future of medicine," said FDA Commissioner Scott Gottlieb, adding that "we're actively developing a new regulatory framework to promote innovation in this space, and support the use of AI-based technologies."

  • Gottlieb noted that the agency will look to apply a pre-certification programme, which the FDA established last year for digital health companies, to tools based on AI

  • "We expect to see an increasing number of AI-based submissions in the coming years, starting with medical imaging devices, and we're working with experts in the field," he said.

  • As part of INFORMED, the regulator said it will focus on tools to improve cancer treatment and drug development.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.